Cargando…
Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period—Kenya, 2010–2015
Schistosomiasis control programs are designed to reduce morbidity by providing mass drug administration (MDA) of praziquantel to at-risk populations. We compared morbidity markers between two cohorts of Kenyan schoolchildren that initially had high prevalence of Schistosoma mansoni infections. One c...
Autores principales: | Sircar, Anita D., Mwinzi, Pauline N. M., Onkanga, Isaac O., Wiegand, Ryan E., Montgomery, Susan P., Secor, W. Evan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090338/ https://www.ncbi.nlm.nih.gov/pubmed/29893197 http://dx.doi.org/10.4269/ajtmh.18-0067 |
Ejemplares similares
-
Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya
por: Onkanga, Isaac O., et al.
Publicado: (2016) -
Use of Geospatial Modeling to Predict Schistosoma mansoni Prevalence in Nyanza Province, Kenya
por: Woodhall, Dana M., et al.
Publicado: (2013) -
Evaluation of Urine CCA Assays for Detection of Schistosoma mansoni Infection in Western Kenya
por: Shane, Hillary L., et al.
Publicado: (2011) -
SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020) -
Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections
por: Karanja, Diana M. S., et al.
Publicado: (2017)